WHO Behind FDA Scheme to Skip All Future Clinical Trials for COVID Vaccines

WHO Behind FDA Scheme to Skip All Future Clinical Trials for COVID Vaccines
By Rohane Hamilton/Shutterstock
Toby Rogers
Updated:
0:00

The U.S. Food and Drug Administration (FDA) today, June 28, will vote on the “Future Framework,” a scheme that would allow Pfizer and Moderna to “reformulate” COVID-19 mRNA vaccines in perpetuity, without conducting clinical trials on the new vaccines. 

The “Future Framework” is coming from the World Health Organization, and the Bill & Melinda Gates Foundation is the biggest voluntary contributor to the WHO, so Gates is likely directing the play.

Introduction: The FDA Always Rigs the Game on Behalf of Pharma

Late Friday afternoon, the FDA released its agenda for the Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting that will vote on the Orwellian “Future Framework” on Tuesday, June 28.
Toby Rogers
Toby Rogers
Author
Dr. Toby Rogers has a Ph.D. in political economy from the University of Sydney in Australia and a Master in public policy from the University of California, Berkeley. His research focus is on regulatory capture and corruption in the pharmaceutical industry. Dr. Rogers does grassroots political organizing with medical freedom groups across the country working to stop the epidemic of chronic illness in children. His doctoral thesis, “The Political Economy of Autism,” explored the regulatory history of five classes of toxicants that increase autism risk. He writes about the political economy of public health on his Substack, "uTobian."
Related Topics